Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-18FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for buspirone hydrochloride from Heritage Pharmaceuticals, enabling a generic version of buspirone hydrochlori…
-
FDA approval · 2015-09-09FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram oxalate by Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-08-28FDA Approved: ESCITALOPRAM — Original Application (SOLCO HEALTHCARE US, LLC)
The FDA approved an original application for a generic escitalopram product from Solco Healthcare US, LLC, for the treatment of major depres…
-
FDA approval · 2015-08-26FDA Approved: DULOXETINE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic duloxetine product (ANDA 203197), establishing a generic version of…
-
FDA approval · 2015-07-31FDA Approved: ALPRAZOLAM — Original Application (Aurobindo Pharma Limited)
The FDA approves Aurobindo Pharma Limited's generic alprazolam through an original ANDA submission, authorizing market entry of the generic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-06-30FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Inc.)
The FDA approved Strides Pharma Inc.'s supplemental application for buspirone hydrochloride (generic), expanding approval of a generic buspi…
-
FDA approval · 2015-06-25FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (generic) under an ANDA, confirming the availability of a gene…
-
FDA approval · 2015-05-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved Yaopharma Co., Ltd.'s original application for venlafaxine hydrochloride, authorizing a new generic version of the antidepressa…
-
FDA approval · 2015-05-14FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC, indicating approval of a supplemental gene…
-
FDA approval · 2015-05-01FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2015-04-29FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Buspirone hydrochloride (BuSpar) from Teva Pharmaceuticals USA, Inc., updating the product's…
-
FDA approval · 2015-04-16FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare's supplemental application for a generic escitalopram product.
-
FDA approval · 2014-12-30FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Accord Healthcare Inc.)
FDA approved an original ANDA for buspirone hydrochloride from Accord Healthcare Inc., enabling generic competition for this anxiety medicat…
-
FDA approval · 2014-12-17FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) by Viatris Specialty LLC. The action is to modify labelin…
-
FDA approval · 2014-12-13FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (ESCITSLOPRAM), a generic antidepressant, bringing a generic v…
-
FDA approval · 2014-12-10FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Escitalopram Oxalate from Amneal Pharmaceuticals LLC, enabling a generic version of escitalo…
-
FDA approval · 2014-12-01FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine submitted by Padagis US LLC, adding or updating labeling under the existing NDA.
-
FDA approval · 2014-11-26FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for PAROXETINE (paroxetine hydrochloride) from Zydus Lifesciences Limited, enabling the marketing of…
-
FDA approval · 2014-11-17FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approval of a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, confirming regulatory action on this generic …
-
FDA approval · 2014-11-04FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for escitalopram oxalate (escitalopram) from Sun Pharmaceutical Industries, Inc., approving changes …
-
FDA approval · 2014-10-31FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Alprazolam submitted by Sandoz Inc, related to a generic version of the drug.
-
FDA approval · 2014-10-31FDA Approved: PAROXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original ANDA for paroxetine hydrochloride hemihydrate (paroxetine), making a generic version of the…
-
FDA approval · 2014-10-21FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine extended-release) submitted by Viatris Specialty LLC.
-
FDA approval · 2014-09-26FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for duloxetine from Zydus Lifesciences Limited under an ANDA. The approval involves changes to the a…
-
FDA approval · 2014-09-19FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine by Alembic Pharmaceuticals, enabling a generic venlafaxine product through an ANDA s…